QuantLogix's 5-factor engine currently reads Apnimed, Inc. Common Stock (APMD) as a buy at 51/100 — a bullish setup. Fundamental is the strongest leg at 63/100, while momentum lags at 37/100. APMD trades in the Pharmaceutical Preparations sector with a $1.2B market cap.
Updated · recomputed every few minutes while markets are open.
The score blends five independent reads of the stock — technical (trend and chart structure), momentum (rate of change across horizons), fundamental (valuation, growth and quality), options (positioning and implied volatility) and microstructure (order flow and liquidity) — into one number from 0 to 100. The weights adapt to the ticker; the bars above show the live weight of each factor.
| Score | Band |
|---|---|
| 70–100 | Strong Buy |
| 50–69 | Buy |
| 30–49 | Neutral |
| 16–29 | Sell |
| 0–15 | Strong Sell |
Apnimed, Inc. Common Stock (APMD) reads Buy at 51 out of 100 on QuantLogix's 5-factor quant signal as of Oct 27, 2026, 9:36 AM ET — a bullish read. Fundamental is the strongest factor at 63/100 and momentum is the weakest at 37/100.
QuantLogix's model currently classifies APMD as Buy (51/100). That is a quantitative reading of price, momentum, fundamentals, options and order flow — not a personal recommendation. It recomputes every few minutes, so re-check it before acting and weigh your own goals and risk.
The score is a weighted blend of five factors. For APMD the live weights are technical 36%, momentum 25%, fundamental 13%, microstructure 26%. Scores map to bands: Strong Buy 70–100, Buy 50–69, Neutral 30–49, Sell 16–29, Strong Sell 0–15.
Every QuantLogix signal is logged when it is issued and graded against the live market. Across 6,970 resolved signals the average return is +0.21% per signal. The full, audited record is public at quantlogix.ai/proof.
The signal recomputes every few minutes while markets are open, and this page refreshes within five minutes of each update. It is free to read with no account.
Live 5-factor quant signal — technical, momentum, fundamental, options, and microstructure — recomputed every few minutes. Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. See the verified track record → · Browse all signal scorecards →